+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 90Years
All Genders
ID05652023

Evaluating Quantitative Ultrasound Bladder Vibrometry for Detecting Detrusor Dysfunction and Guiding BPH Treatment in Adults

Led by Mayo Clinic · Updated on 2026-03-27

2023

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry QUBV to detect abnormal bladder function, specifically focusing on detrusor overactivity and benign prostatic hyperplasia BPH treatment selection. This observational study aims to assess how well QUBV works as a noninvasive tool compared to urodynamic studies, which are part of participants regular clinical care. Participants will undergo QUBV ultrasound at the same time as their scheduled urodynamic study or selective photovaporization of the prostate, depending on their diagnosis and treatment plan. The study will include adults aged 18 to 90 years who are already scheduled for these procedures as part of their clinical care. The research will not involve experimental treatments but will observe and compare QUBV results with standard diagnostic methods. During the study, researchers will measure the accuracy of QUBV in determining detrusor pressure and in selecting BPH patients for surgery. Data will be collected up to study completion, averaging one year. Participants will continue with their usual care, and the study involves no additional interventions beyond the ultrasound measurement performed alongside routine procedures.

CONDITIONS

Brief Title

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

Research Team

A

Azra Alizad, MD

K

Kathryn (Katie) Barthels

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here